Public consultation on 18 substances proposed for authorisation under REACH

ECHA/NR/18/47

ECHA invites comments on its proposal to include 18 new substances in the REACH Authorisation List. Comments can be given until 5 December 2018.

Helsinki, 5 September 2018 – ECHA is considering recommending the Commission to include 18 substances in the Authorisation List (Annex XIV to REACH). The substances are listed in the annex to this news release.

ECHA invites comments and further information on the uses of the substances and possible exemptions from the authorisation requirement as well as information on the structure and complexity of the supply chains.

In parallel to ECHA’s public consultation, the European Commission is calling for information on the possible socio-economic consequences of including these 18 substances in the Authorisation List. The information received will be passed on directly to the Commission and will not be considered by ECHA.

If a substance is included in the Authorisation List, it can only be placed on the market or used after a given date if an authorisation is granted for a specific use. Companies that are using, manufacturing or importing these substances can apply for authorisation.

ECHA regularly recommends substances from the Candidate List for inclusion in the Authorisation List to the Commission. The draft recommendation is based on an assessment of the data in REACH registration dossiers and other available information, and an initial consultation with the Member State Committee. Registrations will be checked for any updates at the end of the public consultation.

Next steps

The Member State Committee will prepare an opinion on ECHA’s draft recommendation taking into account the comments received during the public consultation. Based on the opinion of the Committee and the public consultation, ECHA will provide its final recommendation to the European Commission. This will be ECHA’s ninth recommendation. The Commission will decide on which of the substances to include in the Authorisation List and on the respective conditions applicable for each substance.